Response to letter entitled: Re: Efficacy and safety of regorafenib in patients with metastatic or locally-advanced chondrosarcoma: Results of a non-comparative, randomised, double-blind, placebo controlled, multicentre phase II study

European Journal of Cancer ◽

10.1016/j.ejca.2021.08.009 ◽

2021 ◽

Author(s):

Florence Duffaud ◽

Camille Schiffler ◽

Sylvie Chabaud ◽

Jean-Yves Blay

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Locally Advanced ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Multicentre Phase

Download Full-text

Efficacy and safety of regorafenib in patients with metastatic or locally advanced chondrosarcoma: Results of a non-comparative, randomised, double-blind, placebo controlled, multicentre phase II study

European Journal of Cancer ◽

10.1016/j.ejca.2021.03.039 ◽

2021 ◽

Vol 150 ◽

pp. 108-118

Author(s):

Florence Duffaud ◽

Antoine Italiano ◽

Emannuelle Bompas ◽

Maria Rios ◽

Nicolas Penel ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Locally Advanced ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Multicentre Phase

Download Full-text

Re: Efficacy and safety of regorafenib in patients with metastatic or locally-advanced chondrosarcoma: Results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre phase II study

European Journal of Cancer ◽

10.1016/j.ejca.2021.06.060 ◽

2021 ◽

Author(s):

Deborah Zhou ◽

Elizabeth Connolly ◽

Madeleine Strach ◽

Vivek Bhadri ◽

Peter Grimison

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Locally Advanced ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Multicentre Phase

Download Full-text

Efficacy and Safety of Additional 200-mg Dose of Celecoxib in Adult Patients With Postoperative Pain Following Extraction of Impacted Third Mandibular Molar: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase II Study in Japan

Clinical Therapeutics ◽

10.1016/j.clinthera.2012.01.004 ◽

2012 ◽

Vol 34 (2) ◽

pp. 314-328 ◽

Author(s):

Ken‘ichi Saito ◽

Akihiro Kaneko ◽

Katsuyuki Machii ◽

Hiroyoshi Ohta ◽

Masayuki Ohkura ◽

...

Keyword(s):

Postoperative Pain ◽

Phase Ii ◽

Phase Ii Study ◽

Adult Patients ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Mandibular Molar

Download Full-text

A Randomized, Double-Blind, Placebo-Controlled Phase II Study of the Efficacy and Safety of Monotherapy Ontuxizumab (MORAb-004) Plus Best Supportive Care in Patients with Chemorefractory Metastatic Colorectal Cancer

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-17-1558 ◽

2017 ◽

Vol 24 (2) ◽

pp. 316-325 ◽

Author(s):

Axel Grothey ◽

Jonathan R. Strosberg ◽

Lindsay A. Renfro ◽

Herbert I. Hurwitz ◽

John L. Marshall ◽

...

Keyword(s):

Colorectal Cancer ◽

Supportive Care ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Best Supportive Care ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Randomized, Double-Blind, Placebo-Controlled Phase II Study of Single-Agent Oral Talactoferrin in Patients With Locally Advanced or Metastatic Non–Small-Cell Lung Cancer That Progressed After Chemotherapy

Yearbook of Oncology ◽

10.1016/j.yonc.2012.06.021 ◽

2012 ◽

Vol 2012 ◽

pp. 185-186

Author(s):

A.S. Tsao

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Single Agent ◽

Locally Advanced ◽

Small Cell Lung ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Efficacy and safety of rebamipide liquid for chemoradiotherapy-induced oral mucositis in patients with head and neck cancer: a multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II study

10.1186/s12885-017-3295-4 ◽

2017 ◽

Vol 17 (1) ◽

Author(s):

T. Yokota ◽

T. Ogawa ◽

S. Takahashi ◽

K. Okami ◽

T. Fujii ◽

...

Keyword(s):

Head And Neck Cancer ◽

Head And Neck ◽

Phase Ii ◽

Neck Cancer ◽

Oral Mucositis ◽

Phase Ii Study ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Download Full-text

A double-blind, placebo-controlled phase II study of the efficacy and safety of 2,2-dimethylbutyrate (HQK-1001), an oral fetal globin inducer, in sickle cell disease

American Journal of Hematology ◽

10.1002/ajh.23725 ◽

2014 ◽

Vol 89 (7) ◽

pp. 709-713 ◽

Author(s):

Marvin E. Reid ◽

Amal El Beshlawy ◽

Adlette Inati ◽

Abdullah Kutlar ◽

Miguel R. Abboud ◽

...

Keyword(s):

Sickle Cell Disease ◽

Sickle Cell ◽

Phase Ii ◽

Phase Ii Study ◽

Efficacy And Safety ◽

Cell Disease ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

459 - Efficacy and Safety of Novel 5-HT4 Agonist DSP-6952 in Patients with Irritable Bowel Syndrome with Constipation: A Randomized, Double-Blind, Placebo-Controlled Early Phase II Study

Gastroenterology ◽

10.1016/s0016-5085(18)30793-5 ◽

2018 ◽

Vol 154 (6) ◽

pp. S-106-S-107 ◽

Author(s):

Shin Fukudo ◽

Masatoshi Nakamura ◽

Hiroto Miwa

Keyword(s):

Irritable Bowel Syndrome ◽

Phase Ii ◽

Early Phase ◽

Phase Ii Study ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Irritable Bowel

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of ustekinumab in Japanese patients with severe atopic dermatitis: a randomized, double-blind, placebo-controlled, phase II study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727446943.793555535 ◽

2019 ◽

Author(s):

Carsten Flohr

Keyword(s):

Atopic Dermatitis ◽

Phase Ii ◽

Phase Ii Study ◽

Japanese Patients ◽

Severe Atopic Dermatitis ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

A randomized, double-blind, placebo-controlled, multicenter phase II study to compare the efficacy and safety of sorafenib added to standard treatment with topotecan to standard treatment alone in patients with platinum-resistant recurrent ovarian cancer (TRIAS): Results of a NOGGO-AGO intergroup pilot-study.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.e15548 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. e15548-e15548

Author(s):

K. El Khalfaoui ◽

S. Mahner ◽

R. Richter ◽

F. Hilpert ◽

R. Lorenz ◽

...

Keyword(s):

Ovarian Cancer ◽

Pilot Study ◽

Phase Ii ◽

Standard Treatment ◽

Phase Ii Study ◽

Recurrent Ovarian Cancer ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Multicenter Phase

Download Full-text